The American Journal of Managed Care > May 2020
The American Journal of Managed Care - May 2020
May 13, 2020 – Juliana Ferri-Guerra, MD; Y. Nadeem Mohammed, MD; Raquel Aparicio-Ugarriza, PhD; Douglas Salguero, MD; Aakashi Shah, MD; Dhanya Baskaran, MD; Marianne Desir, MD; and Jorge G. Ruiz, MD
Despite previous research evidence, this study did not reveal an overall association of health literacy, numeracy, and graph literacy with all-cause hospitalizations or mortality.
May 13, 2020 – Renu S. Goyal, MD
The revolving door of readmissions keeps spinning for patients who report symptoms of shortness of breath.
April 06, 2020 – A. Mark Fendrick, MD; and Beth Shrosbree, BS
The coronavirus disease 2019 (COVID-19) pandemic will exacerbate the financial situations of the millions of Americans who struggle to afford their medical care, but policy solutions are available to quickly mitigate this problem.
May 15, 2020 – Interview by Allison Inserro
To mark the 25th anniversary of the journal, each issue in 2020 will include an interview with a healthcare thought leader. For the May issue, we turned to Larry Levitt, MPP, executive vice president for health policy for the Kaiser Family Foundation.
May 12, 2020 – Lexie R. Grove, MSPH; Marisa Elena Domino, PhD; Joel F. Farley, PhD; Karen E. Swietek, PhD; Christopher Beadles, MD, PhD; Alan R. Ellis, PhD, MSW; Carlos T. Jackson, PhD; and C. Annette DuBard, MD, MPH
Medical home enrollment had mixed effects on acute care use and a large effect on outpatient care use. Effects on expenditures varied by mental illness.
March 26, 2020 – Alice J. Chen, PhD; Rocio Ribero, PhD; and Karen Van Nuys, PhD
The speed and extent of biosimilar penetration differ across provider types. Provider awareness and incentives are significantly associated with biosimilar uptake.
TRENDS FROM THE FIELD
Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems
May 14, 2020 – David Muhlestein, PhD, JD; Tianna Tu, BA; and Carrie H. Colla, PhD
Since 2015, the majority of new accountable care organizations (ACOs) have been led by physician groups rather than hospital systems. This shift requires policies that address the characteristic strengths and weaknesses of physician-led ACOs.
May 05, 2020 – Tushar Sharma, MD; Rohit Chaudhary, MIS; Jalaj Garg, MD; Ashok Kondur, MD; Divyanshu Mohananey, MD; and Rahul Chaudhary, MD
Specific measures using a Six Sigma approach led to sustained reduction of door-to-balloon times among patients with ST-segment elevation myocardial infarction (STEMI) in a community setting.
May 06, 2020 – Michael R. Bogart, PharmD; Sari D. Hopson, PhD, MSPH; Huai-Che Shih, PhD; Richard H. Stanford, PharmD, MS; and Anna D. Coutinho, PhD, BPharm
Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.
May 07, 2020 – M. Thomas Bateman Jr, PharmD; Caitlin McCarthy, PharmD; and Kemi Alli, MD
This manuscript describes a new interdisciplinary model for scheduling new patients with a clinical pharmacist and a primary care provider to increase productivity.
May 08, 2020 – Setareh A. Williams, PhD; Benjamin Chastek, MS; Kevin Sundquist, MS; Sergio Barrera-Sierra, MD; Deane Leader Jr, PhD, MBA; Richard J. Weiss, MD; Yamei Wang, PhD; and Jeffrey R. Curtis, MD
Osteoporotic fractures are associated with a significant economic burden, including costs of rehabilitation services and a high total all-cause cost of care.
May 11, 2020 – Maya Leventer-Roberts, MD, MPH; Chandra Cohen-Stavi, MPA; Moshe Hoshen, PhD; Ilan Gofer, BA; Michael Sherf, MD; and Ran Balicer, MD, PhD, MPH
Ambulatory care–sensitive conditions can be systematically assessed in a large electronic medical database to describe admission rates by year, catchment area, and hospital affiliation.